Details for New Drug Application (NDA): 210568
✉ Email this page to a colleague
The generic ingredient in CEFPODOXIME PROXETIL is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
Summary for 210568
Tradename: | CEFPODOXIME PROXETIL |
Applicant: | Alkem Labs Ltd |
Ingredient: | cefpodoxime proxetil |
Patents: | 0 |
Suppliers and Packaging for NDA: 210568
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 210568 | ANDA | Golden State Medical Supply, Inc. | 51407-083 | 51407-083-20 | 20 TABLET, FILM COATED in 1 BOTTLE (51407-083-20) |
CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 210568 | ANDA | Golden State Medical Supply, Inc. | 51407-084 | 51407-084-20 | 20 TABLET, FILM COATED in 1 BOTTLE (51407-084-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | May 18, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | May 18, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription